RDJ advises Solvotrin Therapeutics on €6.7m financing

RDJ advised Solvotrin Therapeutics on its recent €6.7m financing by London-based RAB Capital and existing investor Elkstone Ventures.

The Cork-based healthcare company manufactures a number of ‘active iron’ products. The group’s supplements are currently sold in a number of EU countries, the US, China, and New Zealand, as well as globally through Amazon.

The company said its new funding will be used to support expansion in international markets including the US, China, India and the Middle East.

Gillian Keating, John Cuddigan, Marie Gavin and Kate Murphy advised on the transaction.